COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic


Summary

Most survey respondents from the Pharmaceuticals sector confirmed that technology purchase decisions in their enterprises are jointly taken by all parties involved.

Most survey respondents also revealed that the intended ICT budget of their enterprises for 2020 would decrease following the COVID-19 outbreak from what it was before the outbreak.

With regards to communications & collaboration investments, ’UCC’ is the communication & collaboration software that most enterprises in the pharmaceuticals sector are considering investing in over the next two years, while VoIP service, dedicated internet/leased line, fiber broadband, and web/video/audio conferencing service are the communications & collaboration service types that most enterprises in the pharmaceuticals sector would invest over the next two years.

The survey also reveals that IoT, ’network sensors’ and ’enterprise IoT platform’ will be the hardware and software categories that will receive investments from most enterprises in the pharmaceuticals sector in the next two years.


Scope

The survey report provides information and insights into ICT spending by enterprises in Pharmaceuticals -

  • Insights of its ICT budget allocation by business function and key spending areas
  • Enterprise ICT Budget Outlook for 2020
  • Enterprise ICT Budget Allocations in 2020 vs. 2019, including the effect of COVID-19 on budget allocations
  • Segment wise ICT budget allocation comparison between 2019 and 2021




Reasons To Buy

  • Gain insights into Pharmaceuticals enterprises ICT spending trends
  • Gain insights into Pharmaceuticals enterprises ICT budget allocation for 2020
  • Gain insights into effect of COVID-19 on ICT budget of enterprises in Pharmaceuticals sector.
  • Gain insights into key technology priorities of the Pharmaceuticals enterprises in allocating ICT budgets